Histone Deacetylase Inhibitors [MoA] - N0000175071

Pharmacologic Class Information

Pharmacologic Code N0000175071
Pharmacologic Name Histone Deacetylase Inhibitors
Pharmacologic Uses
  • histone deacetylase (HDAC) inhibitor
Pharmacologic Concept Mechanisms of Action - [MoA]
Pharmacologic Concept Description This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Histone Deacetylase Inhibitors

The following table contains 10 products whose active ingredient are classified under the same pharmacologic class Histone Deacetylase Inhibitors [MoA].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
0006-0568Zolinza Non-Proprietary Name: VorinostatCapsuleOralMerck Sharp & Dohme LlcACTIVE
0078-0650Farydak Non-Proprietary Name: PanobinostatCapsuleOralNovartis Pharmaceuticals CorporationACTIVE
0078-0651Farydak Non-Proprietary Name: PanobinostatCapsuleOralNovartis Pharmaceuticals CorporationACTIVE
0078-0652Farydak Non-Proprietary Name: PanobinostatCapsuleOralNovartis Pharmaceuticals CorporationACTIVE
0703-4004Romidepsin Non-Proprietary Name: RomidepsinInjection, Solution, ConcentrateIntravenousTeva Parenteral Medicines, Inc.ACTIVE
68152-108Beleodaq Non-Proprietary Name: BelinostatInjection, Powder, Lyophilized, For SolutionIntravenousAcrotech Biopharma LlcACTIVE
72893-002Beleodaq Non-Proprietary Name: BelinostatInjection, Powder, Lyophilized, For SolutionIntravenousAcrotech Biopharma LlcACTIVE
73116-100Farydak Non-Proprietary Name: PanobinostatCapsuleOralSecura Bio, Inc.ACTIVE
73116-101Farydak Non-Proprietary Name: PanobinostatCapsuleOralSecura Bio, Inc.ACTIVE
73116-102Farydak Non-Proprietary Name: PanobinostatCapsuleOralSecura Bio, Inc.ACTIVE